Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of Peramivir Inhalation Solution in Uncomplicated Influenza
CTR20252729Phase 2Active
- Sponsor
- Langtian Pharmaceutical
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of peramivir in Influenza A infection, influenza B, sponsored by Langtian Pharmaceutical. Started Sep 2025; status: active.
02
Drugs
peramivir
03
Conditions
Influenza A infectioninfluenza B
Beyond the preview
Go deeper on CTR20252729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252729.